Based in Rehovot, Israel's main biotech hub, the fund exclusively invests in biotech companies developing drugs at or near clinical stages. With a team of 25 venture advisors and partnerships with top-tier international pharmaceutical companies, institutional investors, family offices, and high net worth individuals, the fund provides hands-on guidance and resources for long-term sustainable growth. Their goal is to strengthen Israel's biotech industry, increase investment opportunities, and realize its full potential.